Sierra C
Unidad de Hipertensión Arterial y Riesgo Vascular, Sección de Geriatría/Hospital de Día para el Paciente Crónico Complejo, Servicio de Medicina Interna, Hospital Clínic de Barcelona, IDIBAPS, Universidad de Barcelona, Barcelona, España.
Hipertens Riesgo Vasc. 2017;34 Suppl 2:26-29. doi: 10.1016/S1889-1837(18)30072-2.
The elevation of systolic blood pressure (BP) is a particularly significant event in the elderly population, where it is estimated that over 68% of the population is hypertensive. Treatment of hypertension in the elderly population is quite beneficial, but it would be necessary take into account some special characteristics of these patients, such as altered pharmacokinetics, comorbidity, or polypharmacy. The available evidence in individuals aged> 80 years seems to indicate that antihypertensive treatment results in a reduction of cardiovascular morbidity and mortality. In any case, it is advisable to individualize treatment and it should assess their quality of previous life, their life expectancy and cardiovascular risk situation. The BP from which to establish drug treatment or reduction targets to achieve BP are the points discussed in different international guidelines. © 2017 SEHLELHA. Published by Elsevier España, S.L.U. All rights reserved.
收缩压升高在老年人群中是一个尤为重要的情况，据估计该人群中超过68%患有高血压。老年人群高血压的治疗颇为有益，但有必要考虑这些患者的一些特殊特征，如药代动力学改变、合并症或多种药物联合使用。年龄大于80岁个体的现有证据似乎表明，抗高血压治疗可降低心血管发病率和死亡率。无论如何，建议进行个体化治疗，并且应该评估他们以前的生活质量、预期寿命和心血管风险状况。关于确定药物治疗的血压水平或实现血压降低目标的血压值是不同国际指南中讨论的要点。© 2017 SEHLELHA。由爱思唯尔西班牙有限公司出版。保留所有权利。
